UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
“Swiss Army Knife” black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment Journal article
Guowang Cheng, Zhongjun Li, Yujing Liu, Rui Ma, Xiaojia Chen, Wen Liu, Yafang Song, Yuan Zhang, Guangtao Yu, Zhenfeng Wu, Tongkai Chen. “Swiss Army Knife” black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment[J]. Journal of Controlled Release, 2022, 353, 752-766.
Authors:  Guowang Cheng;  Zhongjun Li;  Yujing Liu;  Rui Ma;  Xiaojia Chen; et al.
Favorite | TC[WOS]:11 TC[Scopus]:13  IF:10.5/10.6 | Submit date:2023/02/01
Parkinson's Disease  Neuroinflammation  Α-synuclein  Blood-brain Barrier  Black Phosphorus Nanosheets  Neuroprotection  
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer Journal article
Cao, Bihui, Liu, Manting, Wang, Lu, Zhu, Kangshun, Cai, Mingyue, Chen, Xiaopei, Feng, Yunfei, Yang, Shuo, Fu, Shengyu, Zhi, Cheng, Ye, Xiaodie, Zhang, Jian, Zhang, Zhiru, Yang, Xin, Zhao, Ming, Wu, Qingde, Xu, Linfeng, Yang, Lili, Lian, Hui, Zhao, Qi, Zhang, Zhenfeng. Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer[J]. Nature Communications, 2022, 13(1), 6203.
Authors:  Cao, Bihui;  Liu, Manting;  Wang, Lu;  Zhu, Kangshun;  Cai, Mingyue; et al.
Favorite | TC[WOS]:48 TC[Scopus]:48  IF:14.7/16.1 | Submit date:2023/01/30
Growth  Antibody  Thermal Ablation  Receptor Tyrosine Kinases  
Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson's Disease Journal article
Wang, Qun, Ma, Rui, Liu, Piaoxue, Cheng, Guowang, Yang, Qi, Chen, Xiaojia, Wu, Zhenfeng, Yuan, Dongsheng, Chen, Tongkai. Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson's Disease[J]. Pharmaceutics, 2022, 14(8), 1731.
Authors:  Wang, Qun;  Ma, Rui;  Liu, Piaoxue;  Cheng, Guowang;  Yang, Qi; et al.
Favorite | TC[WOS]:11 TC[Scopus]:10  IF:4.9/5.5 | Submit date:2022/08/26
Polymeric Nanoparticles  Blood-brain Barrier  Drug Delivery  Pharmacokinetics  Brain Accumulation  Parkinsonian Therapy  
Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors Journal article
Jiang, Zhiwu, Cheng, Lin, Wu, Zhiping, Zhou, Linfu, Wang, Haitao, Hong, Qilan, Wu, Qiting, Long, Youguo, Huang, Yunlin, Xu, Gaoqi, Yao, Yao, Tang, Zhaoyang, Zhang, Zhenfeng, Yang, Lili, Luo, Wei, Yang, Jie, Gong, Likun, Liu, Pentao, Chen, Xinwen, Cui, Shuzhong, Zhang, Qi, Li, Yinxiong, Li, Peng. Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors[J]. EMBO Reports, 2022, 23(6), e54275.
Authors:  Jiang, Zhiwu;  Cheng, Lin;  Wu, Zhiping;  Zhou, Linfu;  Wang, Haitao; et al.
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:6.5/8.3 | Submit date:2022/05/17
Biomarkers  Hepatocellular Carcinoma  Humanized Mouse Models  Immunotherapy  Oncogenes  
Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials Journal article
Guowang Cheng, Yujing Liu, Rui Ma, Guopan Cheng, Yucheng Guan, Xiaojia Chen, Zhenfeng Wu, Tongkai Chen. Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials[J]. Nano-Micro Letters, 2022, 14(1), 105.
Authors:  Guowang Cheng;  Yujing Liu;  Rui Ma;  Guopan Cheng;  Yucheng Guan; et al.
Favorite | TC[WOS]:48 TC[Scopus]:46  IF:31.6/26.0 | Submit date:2022/05/13
Biomimetic Drug Delivery  Blood–brain Barrier  Nano-biological Effects  Nasal Delivery  Parkinson’s Disease  
Black Phosphorus-Based Nanotherapeutics to Overcome the Blood-Brain Barrier for Parkinson's Disease Conference paper
Cheng, Guowang, Luo, Jingshan, Liu, Yao, Chen, Xiaojia, Wu, Zhenfeng, Chen, Tongkai. Black Phosphorus-Based Nanotherapeutics to Overcome the Blood-Brain Barrier for Parkinson's Disease[C], Guangzhou:The 7th Nano Today Conference, 2021.
Authors:  Cheng, Guowang;  Luo, Jingshan;  Liu, Yao;  Chen, Xiaojia;  Wu, Zhenfeng; et al.
Favorite |  | Submit date:2022/08/02
Black Phosphorus Nanosheets  Blood-brain Barrier  Noninvasive Targeted Delivery  Α-synuclein  
Cucurbituril-Oriented Nanoplatforms in Biomedical Applications Journal article
Cheng, Guowang, Luo, Jingshan, Liu, Yao, Chen, Xiaojia, Wu, Zhenfeng, Chen, Tongkai. Cucurbituril-Oriented Nanoplatforms in Biomedical Applications[J]. ACS Applied Bio Materials, 2020, 3(12), 8211-8240.
Authors:  Cheng, Guowang;  Luo, Jingshan;  Liu, Yao;  Chen, Xiaojia;  Wu, Zhenfeng; et al.
Favorite | TC[WOS]:15 TC[Scopus]:13  IF:4.6/4.4 | Submit date:2021/03/02
Cancer Therapy  Cucurbiturils  Drug Delivery  Host-guest Systems  Supramolecular  
Nanoparticles mediating the sustained puerarin release facilitate improved brain delivery to treat parkinson's disease Journal article
Chen, Tongkai, Liu, Wei, Xiong, Sha, Li, Dongli, Fang, Shuhuan, Wu, Zhenfeng, Wang, Qi, Chen, Xiaojia. Nanoparticles mediating the sustained puerarin release facilitate improved brain delivery to treat parkinson's disease[J]. ACS Applied Materials and Interfaces, 2019, 11(48), 45276-45289.
Authors:  Chen, Tongkai;  Liu, Wei;  Xiong, Sha;  Li, Dongli;  Fang, Shuhuan; et al.
Favorite | TC[WOS]:73 TC[Scopus]:80  IF:8.3/8.7 | Submit date:2021/03/02
Brain Delivery  Nanoparticles  Neuroprotective Effects  Puerarin  Sustained Release